Trump imposes major new tariffs on imported patented pharmaceuticals.
What it does:
• 100% tariff on many imported patented (brand-name) drugs and key pharmaceutical ingredients
• 15% tariff for some trade partners, including the EU, Japan, South Korea, Switzerland, and Liechtenstein
• UK imports may face even lower tariffs under a separate deal
• 20% tariff options for companies that commit to building or expanding drug manufacturing in the US
• 0% tariff option for firms joining approved US programs tied to boosting domestic supply
• Generic drugs are not targeted for now$CTSI
CTSI
0.03151
-0.53%
YB
--
--
STO
0.1152
-1.87%